Lithium has not been shown to reverse Alzheimer's disease in people. The headlines come from laboratory work, including a 2025 study using lithium orotate in mice. That work gives researchers a promising question to test, not an established treatment.
Does any study show lithium reversing Alzheimer's in people?
No human study demonstrates reversal of Alzheimer's with lithium. The human population literature is observational and concerns risk, associations between higher lifelong trace-lithium exposure and lower dementia rates, not reversal of established disease. The largest, a Danish nested case-control analysis by Kessing and colleagues (2017; 73,731 dementia cases), found a non-linear association with dementia incidence (DOI). That is about who develops dementia, not about reversing it once present. For the wider picture, see lithium and dementia.
What did the 2025 lithium study actually show?
The study examined human brain tissue and used mouse experiments to investigate lithium availability. In mice, lithium depletion worsened measurements including amyloid and tau changes and memory performance. The orotate experiments examined whether replacement could prevent or improve changes in those models.
Prevention and reversal are different claims. Results in an animal model do not establish either claim for people with Alzheimer’s. Read the study.
Is it proven in humans?
A 2026 randomized trial tested lithium carbonate in 80 older adults with mild cognitive impairment over two years. It did not meet its prespecified primary outcome thresholds. Earlier small trials reported encouraging findings, so the human evidence is mixed. The carbonate trial did not directly test orotate, but its result is not evidence that orotate works or that amyloid binding explains the outcome. Read the trial; compare the human studies.
This is why a headline about mice should not become a claim that lithium reverses Alzheimer’s in people. For the fuller clinical history, use the linked evidence guide.
Why don't mouse results mean lithium reverses human Alzheimer's?
Animal findings are among the weaker forms of evidence for human benefit, and many interventions that change markers in mice fail in human trials. Several factors limit translation:
| Factor | Why it limits translation |
|---|---|
| Species differences | Mouse metabolism, lifespan, and brain biology differ from humans |
| Dose translation | Doses effective in rodents do not necessarily map to humans |
| Model limitations | Mouse models reproduce some, but not all, features of human Alzheimer's |
| Markers vs outcomes | Changing biomarkers in mice is not the same as restoring human cognition |
For more on the proposed biology, see how lithium works in the brain.
Limitations and safety
No human data support reversing Alzheimer's with lithium, and no health authority recommends lithium for this purpose. Prescription lithium is a medication with serious risks that requires clinical monitoring, and the long-term safety of low-dose supplemental lithium is not well characterized. None of this research supports self-treating with lithium in any form. This article is educational and is not medical advice. For the full picture across forms and doses, see lithium and the brain.
Frequently asked questions
Can lithium cure or reverse Alzheimer's?
No. There is no human evidence that lithium cures or reverses Alzheimer's. Observational studies concern dementia risk, not reversal, and the 2025 findings (Aron and colleagues, Nature) are from mouse models and human tissue. Reversal is not an established outcome of lithium in people.
Is lithium a treatment for Alzheimer's?
Lithium is not an approved or established treatment for Alzheimer's disease. The 2026 randomized lithium carbonate trial of low-dose lithium in mild cognitive impairment (2026) did not meet its primary outcomes, and earlier small trials were encouraging but do not establish treatment efficacy.
Did the 2026 lithium trial show it does not work?
A 2026 randomized trial tested lithium carbonate in 80 older adults with mild cognitive impairment over two years. It did not meet its prespecified primary outcome thresholds. Earlier small trials reported encouraging findings, so the human evidence is mixed. The carbonate trial did not directly test orotate, but its result is not evidence that orotate works or that amyloid binding explains the outcome. Read the trial; compare the human studies.
Why isn't promising mouse data enough?
Animal results establish biological plausibility, but many interventions that change markers in mice fail in human trials due to species, dose, and model differences. Demonstrating an effect in mice is a research starting point, not evidence that lithium reverses Alzheimer's in people.
